Molecular Cytogenetics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Molecular Cytogenetics Market is segmented by Products (Kits & Reagents, Instruments, and Software & Services), Technique, Application, and Geography

Molecular Cytogenetics Market Snapshot

Molecular Cytogenetics Market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The molecular cytogenetics deals with all aspects of chromosome biology with a wide range of applications in disease diagnosis and chromosomal abnormalities. The growing prevalence of cancer and genetic disorders patients has a direct rising impact on the increased demand of the molecular cytogenetic market. According to the World Health Organization (WHO), cancer is the second most important cause of death and morbidity in Europe, with more than 3.7 million new cases and 1.9 million deaths each year, with tobacco and excessive alcohol consumption being the primary reasons. The genetic data accumulated each day are closely associated with the diagnosis and prognosis of neoplasm, thus widening the scope of cancer cytogenetics in various practices. Genetic diseases and their connections with brain disorders, such as Down syndrome, Edwards’s syndrome, Patau syndrome, and Turner syndrome are among the few prominent diseases that have several applications in molecular cytogenetics. Thus, with the increasing prevalence of cancers and genetic diseases, the demand for molecular cytogenetics is expected to register significant rise in the forecast years.

Scope of the Report

As per the scope of the report, cytogenetic approaches are needed for the detection of chromosome instability, which helps in the identification of gross genomic variations. The molecular cytogenetic techniques are used to refine the variations detected by cytogenetic analysis, for the identification of subtle genomic variations.

By Products
Kits & Reagents
Software & Services
By Technique
Fluorescence in Situ Hybridization
Comparative Genomic Hybridization
Other Techniques
By Application
Genetic Disorders
Other Applications
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Cancer Segment is Expected to Show Better Growth over the Forecast Period

Based on application, it is segmented into cancer, genetic disorders and other applications. Molecular cytogenetics has played an important role in rapid and precise characterization of cancer chromosome abnormalities. Oncology deals with the diagnosis and treatment of tumors and cancers. Cancer is one of the leading causes of morbidity and mortality. Among both sexes, lung, breast, and colorectal cancers are among the most common cancers in the world, with lung cancer alone contributing to more than 13% of the total cases diagnosed. Thus, with the increasing burden of cancer, the demand for diagnosis is increasing, resulting in the high growth of the studied market.

Molecular Cytogenetics Market

North America is Expected to Dominate the Molecular Cytogenetics Market

The molecular cytogenetics market dominate the North America region due to better healthcare infrastructure, effective government policies, huge base of multinational companies, and high awareness among people. Molecular cytogenetics tests are covered under the National Insurance Policy, in Medicare. The major focus has been on the Centers for Medicare and Medicaid Services. Furthermore, growing geriatric population, along with increasing demand for in-vitro diagnostics testing for the detection of various chronic diseases is expected to drive the market over the forecast period.

Molecular Cytogenetics Market 2

Competitive Landscape

The global players into the molecular cytogenetics market are Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F.Hoffmann-La Roche Ltd., Illumina, Inc., Oxford Gene Technology, PerkinElmer Inc, Quest Diagnostics and Thermo Fisher Scientific.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Prevalence of Cancer and Genetic Disorders

      2. 4.2.2 Increasing Focus on Targeted Therapies for Cancer Treatment

      3. 4.2.3 Rise in Funding for Research and Clinical Diagnosis

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Treatment

      2. 4.3.2 Lack of Awareness about the Emerging Diagnostic Technologies in Cytogenetics

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Products

      1. 5.1.1 Instruments

      2. 5.1.2 Kits & Reagents

      3. 5.1.3 Software & Services

    2. 5.2 By Technique

      1. 5.2.1 Fluorescence in Situ Hybridization

      2. 5.2.2 Comparative Genomic Hybridization

      3. 5.2.3 Karyotyping

      4. 5.2.4 Other Techniques

    3. 5.3 By Application

      1. 5.3.1 Cancer

      2. 5.3.2 Genetic Disorders

      3. 5.3.3 Other Applications

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Agilent Technologies, Inc.

      3. 6.1.3 Bio-Rad Laboratories, Inc.

      4. 6.1.4 F.Hoffmann-La Roche Ltd.

      5. 6.1.5 Illumina, Inc.

      6. 6.1.6 Oxford Gene Technology

      7. 6.1.7 PerkinElmer, Inc.

      8. 6.1.8 Quest Diagnostics

      9. 6.1.9 Thermo Fisher Scientific

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Molecular Cytogenetics Market market is studied from 2018 - 2026.

The Molecular Cytogenetics Market is growing at a CAGR of 7.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F.Hoffmann-La Roche Ltd., PerkinElmer, Inc., Thermo Fisher Scientific are the major companies operating in Molecular Cytogenetics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!